Author/Creator: Izikson, Ruvim - British Library Electronic Legal Deposit Catalogue-Journal Issues and Articles Search Results

Author/Creator Izikson, Ruvim

1. Randomized comparison of the safety of Flublok® versus licensed inactivated influenza vaccine in healthy, medically stable adults ≥50 years of age. Issue 48 (27th November 2015)

Authors:: Izikson, Ruvim; Leffell, David J.; Bock, S. Allan; Patriarca, Peter A.; Post, Penny; Dunkle, Lisa M.; Cox, Manon M.J.
Journal:: Vaccine
Issue:: Volume 33:Issue 48(2015)
Page Start:: 6622
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

2. Recombinant hemagglutinin influenza vaccine provides broader spectrum protection. (2nd August 2016)

Authors:: Dunkle, Lisa M.; Izikson, Ruvim
Journal:: Expert review of vaccines
Issue:: Volume 15:Number 8(2016)
Page Start:: 957
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

3. Safety and immunogenicity of a high-dose quadrivalent influenza vaccine administered concomitantly with a third dose of the mRNA-1273 SARS-CoV-2 vaccine in adults aged ≥65 years: a phase 2, randomised, open-label study. Issue 4 (April 2022)

Authors:: Izikson, Ruvim; Brune, Daniel; Bolduc, Jean-Sébastien; Bourron, Pierre; Fournier, Marion; Moore, Tamala Mallett; Pandey, Aseem; Perez, Lucia; Sater, Nessryne; Shrestha, Anju; Wague, Sophie; Samson, Sandrine I
Journal:: Lancet
Issue:: Volume 10:Issue 4(2022)
Page Start:: 392
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

4. Safety of Recombinant Influenza Vaccine Compared to Inactivated Influenza Vaccine in Adults: An Observational Study. (20th May 2020)

Authors:: Hansen, John; Goddard, Kristin; Timbol, Julius; Zhang, Lea; Lewis, Ned; Dunkle, Lisa; Izikson, Ruvim; Klein, Nicola P
Journal:: Open forum infectious diseases
Issue:: Volume 7:Number 6(2020)
Page Start:
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

5. Safety of recombinant quadrivalent influenza vaccine compared to inactivated influenza vaccine in Chinese adults: An observational study. Issue 5 (31st January 2022)

Authors:: Hsiao, Amber; Hansen, John; Nunley, Karen Valdez; Lewis, Ned; Selmani, Alex; Inamdar, Ajinkya; Mallett-Moore, Tamala; Izikson, Ruvim; Rudin, Deborah; Klein, Nicola P.
Journal:: Vaccine
Issue:: Volume 40:Issue 5(2022)
Page Start:: 774
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

6. Safety, efficacy, and immunogenicity of Flublok in the prevention of seasonal influenza in adults. (July 2015)

Authors:: Cox, Manon M. J.; Izikson, Ruvim; Post, Penny; Dunkle, Lisa
Journal:: Therapeutic advances in vaccines
Issue:: Volume 3:Number 4(2015:Oct.)
Page Start:: 97
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

7. Stable emulsion (SE) alone is an effective adjuvant for a recombinant, baculovirus-expressed H5 influenza vaccine in healthy adults: A Phase 2 trial. Issue 6 (7th February 2017)

Authors:: Treanor, John J.; Chu, Laurence; Essink, Brandon; Muse, Derek; El Sahly, Hana M.; Izikson, Ruvim; Goldenthal, Karen L.; Patriarca, Peter; Dunkle, Lisa M.
Journal:: Vaccine
Issue:: Volume 35:Issue 6(2017)
Page Start:: 923
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗